Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 8/2013

01-08-2013 | Letter to the Editor

Actinomycotic brain abscess as the first clinical manifestation of hereditary hemorrhagic telangiectasia—case report and review of the literature

Authors: M. Koubaa, D. Lahiani, I. Mâaloul, H. Fourati, L. Chaari, Ch. Marrakchi, Z. Mnif, Z. Boudawara, M. Ben Jemâa

Published in: Annals of Hematology | Issue 8/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24:203–219PubMedCrossRef
2.
Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48:73–87PubMedCrossRef
3.
Mathis S, Dupuis-Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, Ingrand P, Gilbert B, Godenèche G, Neau JP (2012) Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clin Neurol Neurosurg 114:235–240PubMedCrossRef
4.
Sell B, Evans J, Horn D (2008) Brain abscess and hereditary hemorrhagic telangiectasia. South Med J 101:618–625PubMedCrossRef
5.
Dupuis-Girod S, Giraud S, Decullier E, Lesca G, Cottin V, Faure F, Merrot O, Saurin JC, Cordier JF, Plauchu H (2007) Hemorrhagic hereditary telangiectasia (Rendu–Osler disease) and infectious diseases: an underestimated association. Clin Infect Dis 44:841–845PubMedCrossRef
6.
Hall WA (1994) Hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber disease) presenting with polymicrobial brain abscess. Case report. J Neurosurg 81:294–296PubMedCrossRef
7.
Bean W (1953) CLINICAL pathologic conference; hereditary hemorrhagic telangiectasia with pulmonary arteriovenous aneurysms. J Iowa State Med Soc 43:107–115
8.
Ehrenhaft JL, Taber RE (1956) Arteriovenous fistulae and arterial aneurysms of the pulmonary arterial tree. AMA Arch Surg 73:567–577PubMedCrossRef
9.
Woods ML (1998) Hereditary hemorrhagic telangiectasia, pulmonary arteriovenous malformations, and brain abscess. Clin Infect Dis 26(1071):1220–1221CrossRef
10.
Wilkins EG, O'Fearghail M, Carroll JD (1983) Recurrent cerebral abscess in hereditary hemorrhagic telangiectasia. J Neurol Neurosurg Psychiatry 46:963–965PubMedCrossRef
11.
Sobel D, Norman D (1984) CNS manifestations of hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 5:569–573PubMed
12.
Stern WE, Naffziger HC (1953) Brain abscess associated with pulmonary angiomatous malformation. Ann Surg 138:521–531PubMedCrossRef
Metadata
Title
Actinomycotic brain abscess as the first clinical manifestation of hereditary hemorrhagic telangiectasia—case report and review of the literature
Authors
M. Koubaa
D. Lahiani
I. Mâaloul
H. Fourati
L. Chaari
Ch. Marrakchi
Z. Mnif
Z. Boudawara
M. Ben Jemâa
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 8/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-012-1666-0

Other articles of this Issue 8/2013

Annals of Hematology 8/2013 Go to the issue

Letter to the Editor

Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome

Original Article

Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

Original Article

DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center

Original Article

Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificity

Original Article

The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia

Original Article

Homoharringtonine in combination with cytarabine and aclarubicin in the treatment of refractory/relapsed acute myeloid leukemia: a single-center experience
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits